Regulatory News
Thursday, May 19, 2016
Novartis launches new Entresto trials in bid to boost sales
ZURICH, May 19 (Reuters) - Novartis's heart failure
drug Entresto will be subjected to a battery of new trials as
the Swiss drugmaker seeks to boost the medicine after a
disappointing introduction.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment